These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 22920832)

  • 21. Correlation between antibiotic consumption and resistance of Gram-negative bacteria causing healthcare-associated infections at a university hospital in Taiwan from 2000 to 2009.
    Lai CC; Wang CY; Chu CC; Tan CK; Lu CL; Lee YC; Huang YT; Lee PI; Hsueh PR
    J Antimicrob Chemother; 2011 Jun; 66(6):1374-82. PubMed ID: 21436153
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predicting and preventing antimicrobial resistance utilizing pharmacodynamics: part II Gram-negative bacteria.
    Abdelraouf K; Linder KE; Nailor MD; Nicolau DP
    Expert Opin Drug Metab Toxicol; 2017 Jul; 13(7):705-714. PubMed ID: 28486001
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evolution of β-lactams resistance in Gram-negative bacteria in Tunisia.
    Chouchani C; Marrakchi R; El Salabi A
    Crit Rev Microbiol; 2011 Aug; 37(3):167-77. PubMed ID: 21438848
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Emerging plasmid-encoded colistin resistance: the animal world as the culprit?
    Poirel L; Nordmann P
    J Antimicrob Chemother; 2016 Aug; 71(8):2326-7. PubMed ID: 27029849
    [No Abstract]   [Full Text] [Related]  

  • 25. Up against the wall.
    Torres C
    Nat Med; 2010 Jun; 16(6):628-31. PubMed ID: 20526310
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Global travel and Gram-negative bacterial resistance; implications on clinical management.
    Theriault N; Tillotson G; Sandrock CE
    Expert Rev Anti Infect Ther; 2021 Feb; 19(2):181-196. PubMed ID: 32815412
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of a hospital-wide antibiotic restriction policy program on the resistance rates of nosocomial Gram-negative bacteria.
    Antoniadou A; Kanellakopoulou K; Kanellopoulou M; Polemis M; Koratzanis G; Papademetriou E; Poulakou G; Giannitsioti E; Souli M; Vatopoulos A; Giamarellou H
    Scand J Infect Dis; 2013 Jun; 45(6):438-45. PubMed ID: 23336730
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antimicrobial resistance in Europe and its potential impact on empirical therapy.
    Rossolini GM; Mantengoli E
    Clin Microbiol Infect; 2008 Dec; 14 Suppl 6():2-8. PubMed ID: 19040461
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Resistant gram-negative infections.
    Fraimow H; Nahra R
    Crit Care Clin; 2013 Oct; 29(4):895-921. PubMed ID: 24094384
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extended-spectrum beta-lactamases: a brief clinical update.
    Malloy AM; Campos JM
    Pediatr Infect Dis J; 2011 Dec; 30(12):1092-3. PubMed ID: 22105419
    [No Abstract]   [Full Text] [Related]  

  • 31. What is in the pipeline for Gram-negative pathogens?
    Talbot GH
    Expert Rev Anti Infect Ther; 2008 Feb; 6(1):39-49. PubMed ID: 18251663
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In memoriam: John P. Quinn, MD.
    Perez F; Arias CA; Bush K; Drusano GL; Lolans K; Munoz-Price LS; Nicolau DP; Queenan AM; Rice LB; Segreti J; Shlaes DM; Weinstein RA; Bonomo RA
    Clin Infect Dis; 2014 Mar; 58(5):748-50. PubMed ID: 24336826
    [No Abstract]   [Full Text] [Related]  

  • 33. Mechanisms of resistance to beta-lactams in some common Gram-negative bacteria causing nosocomial infections.
    Suárez CJ; Lolans K; Villegas MV; Quinn JP
    Expert Rev Anti Infect Ther; 2005 Dec; 3(6):915-22. PubMed ID: 16307504
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acquired metallo-beta-lactamases: an increasing clinical threat.
    Rossolini GM
    Clin Infect Dis; 2005 Dec; 41(11):1557-8. PubMed ID: 16267726
    [No Abstract]   [Full Text] [Related]  

  • 35. Impact of antibiotic resistance in gram-negative bacilli on empirical and definitive antibiotic therapy.
    Paterson DL
    Clin Infect Dis; 2008 Sep; 47 Suppl 1():S14-20. PubMed ID: 18713045
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predominance of Gram-negative bacilli and increasing antimicrobial resistance in nosocomial bloodstream infections at a university hospital in southern Taiwan, 1996-2003.
    Wu CJ; Lee HC; Lee NY; Shih HI; Ko NY; Wang LR; Ko WC
    J Microbiol Immunol Infect; 2006 Apr; 39(2):135-43. PubMed ID: 16604246
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The emerging threat of multidrug-resistant Gram-negative bacteria in urology.
    Zowawi HM; Harris PN; Roberts MJ; Tambyah PA; Schembri MA; Pezzani MD; Williamson DA; Paterson DL
    Nat Rev Urol; 2015 Oct; 12(10):570-84. PubMed ID: 26334085
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MCR: modern colistin resistance.
    Caniaux I; van Belkum A; Zambardi G; Poirel L; Gros MF
    Eur J Clin Microbiol Infect Dis; 2017 Mar; 36(3):415-420. PubMed ID: 27873028
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bacterial resistance, beta-lactam antibiotics and gramnegative bacteria at ICUs.
    Reisinger EC; Allerberger F
    Wien Klin Wochenschr; 1999 Jul; 111(14):537-8. PubMed ID: 10467639
    [No Abstract]   [Full Text] [Related]  

  • 40. Improving outcomes in the management of Gram-negative bacterial infections in the face of growing antimicrobial resistance.
    Mayor S
    Future Microbiol; 2016 Oct; 11():1223-1226. PubMed ID: 27680185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.